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The paper addresses an inventory model of pharmaceutical products where the demand rate of the
customers increases with the volume of the initiatives of the sales team. In this model, the deterioration
of the product varies depending on on-hand inventory. The volume of sales team initiatives is a control
variable. It is dependent on on-hand inventory and vice versa. The proﬁt function of the farm is
formulated by the trading of inventory costs, purchasing costs, losses due to deterioration and sales team
initiative costs, considering inﬂation and the time value of the monetary cost and proﬁt parameters.
Finally, the proﬁt function is maximized by a variation of the calculus method. A numerical example is
given to justify our model.
Copyright © 2016, Far Eastern Federal University, Kangnam University, Dalian University of Technology,
Kokushikan University. Production and hosting by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Pharmaceutical products are essential commodities in health
caremanagement. Many substitutable pharmaceutical products are
present in the market. Consequently, the managers of pharma-
ceutical farms/companies have to think about new strategies to
capture market demand. Generally, it is observed that medical
representatives act as salesmen of pharmaceutical products. As a
result, the sales team should be composed of qualiﬁed and
knowledgeable pharmacists, doctors and marketing researchers.
For this purpose, investment in the sales team and in sample
medicines of a particular drug is necessary and constitutes impor-
tant cost factors for the ﬁrms. On the other hand, pharmaceutical
products undergo deterioration/decay over time and should not be
neglected in the inventory system.
In the present article, we develop a mathematical model that
considers sales revenue, inventory holding cost, purchasing/pro-
curement cost, loss due to deterioration and investment in sales
team initiatives. Here, the demand for the products in the marketa), shibaji.panda@gmail.com
Federal University, Kangnam
an University.
ersity, Kangnam University, Dalian
C-ND license (http://creativecommhas two parts: one part is ﬁxed, which is the demand of ﬁxed
customers who have a good relationship with the ﬁrm, and other
part is an increasing function of the sales team initiatives in which
the customers are motivated by the awareness activities that the
salesmen use to promote the product. The initiative function of the
salesmen is a control variable. The proﬁt function is maximized by a
variation of the calculus method by trading off sales revenue, in-
ventory holding cost, loss due to deterioration and cost of sales
team initiatives. Finally, optimal values of replenishment and sales
team initiatives are calculated to maximize the proﬁt function.2. Brief review of the literature
In practice, it is observed that perishable pharmaceutical prod-
ucts undergo deterioration over time. Deterioration generally in-
cludes spoilage, obsolescence, evaporation and pilferage of the
products and increases with time. Many researchers have focused
on this topic.Wu et al. (2009) solved an inventory systemwith non-
instantaneous deteriorating items and price-sensitive demands to
determine the optimal sales price and length of the replenishment
cycle such that the total proﬁt per unit of time of the retailer was
maximized. Chang et al. (2010) characterized the optimal solution
and obtained theoretical results to determine the optimal order
quantity and the optimal replenishment time under a discounted
cash-ﬂow (DCF) approach. Jaggi et al. (2011) studied a two-University of Technology, Kokushikan University. Production and hosting by Elsevier
ons.org/licenses/by-nc-nd/4.0/).
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inﬂationary conditions with different rates of deterioration, in
which partial backlogging at the owned warehouse was allowed.
Widyadana et al. (2011) optimized an inventory model for perish-
able items with a simpliﬁed approach, considering the issue with
and without backordering. Ghosh et al. (2011) developed a pro-
duction- inventory model with backlogging for perishable items
with a linear price dependent demand. Sarkar (2012) developed an
economic order quantitymodel for time with a varying demand and
deterioration rate of the items, including trade credit ﬁnancing and
different discount rates on the purchasing costs. Sarkar and Sarkar
(2013) extended an inventory model for time varying deteriorating
items with stock-dependent demand, allowing time varying back-
logging. Sarkar (2013) considered three types of continuous prob-
abilistic deterioration functions in a two-echelon supply chain to
analyse a production-inventory model by a simple algebraic
approach. Goyal et al. (2013) developed an economic production
quantity (EPQ) model for ameliorating/deteriorating items with a
ramp type demand, and they minimized the total relevant cost of
the system by using a genetic algorithm (GA). Taleizadeh et al.
(2015) analysed a Vendor Managed Inventory (VMI) model for a
two-level supply chain to obtain the optimal retail price, the
replenishment frequency of raw material, the replenishment cycle
of the product and the production rate, when both the rawmaterial
and the ﬁnished product have different deterioration rates.
Research in supply chain management of pharmaceutical
products has been extensively applied in the ﬁeld of health care
management. In a pharmaceutical supply chain system, the inte-
gration of all performances involved with the ﬂow of products from
raw materials to the end customers improves the relationship with
the channel members to achieve sustainable competitive oppor-
tunities. According to Aptel and Pourjalali (2001), the management
of pharmaceutical products is a vital managerial issue in health care
industries. Veral and Rosen (2001) showed that one of the long-
term beneﬁts of outsourcing could be a reduction in the number
of suppliers, which results in lower procurement costs for down-
streammembers of the chain. Nicholson et al. (2004) compared the
costs of inventory and service levels for inventory items of an in-
house three-echelon distribution network and outsourced a two-
echelon distribution network. Kim (2005) studied an integrated
supply chain management system, addressing issues related to
drugs in health care sectors. Vernon et al. (2005) suggested both
analytic and simulationmethods for ﬁrms to determine the feasible
range of prices of products considering licensing risk and devel-
opmental Go/No-Go decisions for the payers’ use of the cost-
effectiveness method. Almarsdottir and Traulsen (2005) described
four types of strategies to curb rising pharmaceutical costs and a
taxonomy of strategies for price and proﬁt controls, reimbursement
system charges, other ﬁscal measures, and quality measures. Zhao
et al. (2006) discussed the development of software infrastruc-
ture for scientists in pharmaceutical industries to help manage
information, capture knowledge and provide intelligent decision
support for pharmaceutical product formulations. They provided a
balanced approach to policymaking in an environment with rising
pharmaceutical costs. Lapierre and Ruiz (2007) emphasized
scheduling decisions for supply chains of the products instead of
multi-echelon inventory systems. Meijboom and Obel (2007) ana-
lysed supply chain coordination in the pharmaceutical industry
with multi-location and multi-stage operation systems. Chen and
Whittemore (2008) suggested that the use of an offsite ware-
house to pool resources saved costs on holding inventory by
reducing on-hand inventory. Woosley (2009) indicated that hos-
pital administrators and pharmacy managers suffered due to
complicated distribution networks for inventory management
problems because most hospital administrators and pharmacymanagers were doctors without sufﬁcient knowledge of supply
chain management. Khan and Shefeeq (2009) showed that math-
ematical modelling for controlled drug delivery is invaluable in the
ongoing struggle to develop new and more effective therapies for
the treatment of cancer. Kelle et al. (2012) developed a periodic
review inventory model of pharmaceutical products, applying
operational and tactical strategies. Uthayakumar and Priyan (2013)
investigated a two-echelon pharmaceutical supply chain inventory
model for multiple products, considering permissible delays in
payment and the inventory lead time under some limitations.
Priyan and Uthayakumar (2014) extended the above model for
situations in unclear environments. Cardenas-Barron et al. (2014)
investigated an economic order quantity model in honour of Ford
Whitman Harris. Cardenas-Barron and Sana (2014, 2015) studied a
production inventory model for single andmulti-item products in a
two-echelon supply chain when end customers’ demand varied
according to sales team initiatives.
The rest of the paper is organized as follows: Section 3 includes
notations that are used to develop the proposed model. The
formulation of the model is given in Section 4. Section 5 illustrates
the model with numerical examples. Section 6 analyses the sensi-
tivity analysis of the key parameters and provides somemanagerial
insights for the proposed model. Concluding remarks are given in
Section 7.3. Notation
The following notations are used to discuss the model.
q(t) e On-hand inventory at time ‘t’.
E(t) e The sales team initiatives at time ‘t’, a control variable.
D(E) e Demand rate of the item.
T e The ﬁnite time horizon.
R e Replenishment lot size.
q e Perishable factor (0 < q < 1), a fraction of the on-hand
inventory.
d ¼ (r  i) e r is rate of interest per unit currency ($) per unit
time, and i is inﬂation rate per unit currency ($) per unit time.
ch e Inventory holding cost per unit per unit time.
c0 e Purchasing cost per unit item.
c1 e Cost per unit effort of the sales team.
p e Selling price per unit item.
E0 e Initial level of sales team initiatives.
J e Proﬁt of the objective function.
R*e Optimum value of replenishment lot size.
E*0 e Optimum initial value of the initiatives of the sales team.
J* e Maximum proﬁt of the objective function.4. Formulation of the model
In this model, the demand rate is
DðEÞ ¼ a0 þ a1
ﬃﬃﬃﬃﬃﬃﬃﬃ
EðtÞ
p
(1)
where a0 is ﬁxed demand, which is independent of sales team
initiatives, and a1 is a scale parameter of the demand rate, which is
sensitive to sales team initiatives. The demand rate is an increasing
function of E(t) that is obvious in practice. Generally speaking,
medical representatives are employed to capture the market de-
mand. On the other hand, some pharmaceutical stores employ a
medical practitioner to attract customers and boost sales. Under
this philosophy, customers/patients beneﬁt from the medical
practitioners, and the store owners earn more from selling more
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hand inventory is
dq
dt
¼ qq

a0 þ a1
ﬃﬃﬃﬃﬃﬃﬃﬃ
EðtÞ
p 
with qð0Þ
¼ ðRþ a0Þ and qðTÞ ¼ a0:
(2)
Here, the replenishment size is R, and it is received at the end of
the cycle length T. At this time, the level of the inventory is a0 units
becauseﬁxeddemand ismet using these units to keep goodwillwith
the ﬁxed customers. Quite often, when the lot size (R) is received, it
takes some time to prepare to sell them. In this short timeframe, the
demand of the genuine customers is met from the stock level a0. For
the generality of the model, it is considered to be a non-zero value
and may be considered to be zero, as is done in many articles in the
inventory literature. Therefore, the inventory q(t) initially starts at
(t ¼ 0) with (R þ a0) units and is depleted with the demand rate
mentioned in Eq. (1). The inventory level reaches level a0 at time T.
The cost and earning elements of the model at time ‘t’ are as
follows:
The cost for sales team initiatives is c1E(t). This is proportional to
the volume of initiatives. The cost for holding inventory is chq(t).
The loss due to deterioration is c0qq(t). The purchasing cost of R
units is c0R. Earnings from sales items is pða0 þ a1
ﬃﬃﬃﬃﬃﬃﬃﬃ
EðtÞp Þ. Therefore,
the total proﬁt during the period [0,T], including the time value of
money and inﬂation, is
J ¼
ZT
0
edt
h
p

a0 þ a1
ﬃﬃﬃﬃﬃﬃﬃﬃ
EðtÞ
p 
 c0R c0qqðtÞ
 chqðtÞ  c1EðtÞ
i
dt ¼
ZT
0
pð _q; q; tÞdt
(3)
where
pð _q; q; tÞ ¼edt
h
p

a0 þ a1
ﬃﬃﬃﬃﬃﬃﬃﬃ
EðtÞ
p 
 c0R c0qqðtÞ
 chqðtÞ  c1EðtÞ
i
¼ edt

(
 c1
a21
ð _qðtÞÞ2 
 
pþ 2a0c1
a21
!
ð _qðtÞÞ  2c1q
a21
ðqðtÞ _qðtÞÞ  c1q
2
a21
ðqðtÞÞ2

 
2c1a0q
a21
 pqþ c0qþ ch
!
qðtÞ  c0R
c1a20
a21
)
(4)
Proposition 1: The proﬁt function J is concave in the interval
[0, T].
Proof: The value of J depends on the path q ¼ q(t) in the interval
[0, T]. Let J have an extreme value along the path q ¼ q0(t) for
t 2 [0,T]. Consider a class of neighbourhood curves
q2(t) ¼ q0(t) þ 2x(t), where 2 is a small constant and x(t) is an
arbitrary analytic function of t. Then, the value of J is
Jð2Þ ¼
Z T
0
p2ð _q0ðtÞ þ2 _xðtÞ; q0ðtÞ þ2xðtÞ; tÞ dt. For the concav-
ity of J(2) we may have dJð2Þd2

2¼0
¼ 0 and d2Jð2Þd22

2¼0
<0.
Now, dJð2Þd2 ¼
Z T
0

_xðtÞ vp2
v _q
þ xðtÞ vp2
vq

dt ¼
Z T
0
xðtÞ vp2
vq
dt þ

xðtÞ vp2
v _q
	T
0

Z T
0
xðtÞ d
dt

vp2
v _q

dt ¼
Z T
0
xðtÞ


vp2
vq
 d
dt
vp2
v _q

dt because x(0) ¼ 0 ¼ x(T) as q is ﬁxed at the end points
t ¼ 0 and t ¼ T. Because dJð2Þd2

2¼0
¼ 0,
d
dt

vp
v _q

 vp
vq
¼ 0 (5)
which is a necessary condition for extreme values of J. Differenti-
ating dJð2Þ=d2 with respect to2, we have
d2Jð2Þ
d22
¼
ZT
0
(
_x2
v2p2
v _q2
þ 2x _x v
2p2
vqv _q
þ x2v
2p2
vq2
)
dt: Now; at2
¼ 0;
d2Jð2Þ
d22

2¼0
¼
ZT
0
(
_x2
v2p
v _q2
þ 2x _x v
2p
vqv _q
þ x2v
2p
vq2
)
dt (6)
Now,
vp
vq
¼edt
(
 2c1q
a21
ð _qÞ  2c1q
2
a21
ðqÞ 
 
2c1qa0
a21
 pqþ c0qþ ch
!)
;
vp
v _q
¼ edt
(
 2c1
a21
ð _qÞ 
 
pþ 2a0c1
a21
!
 2c1q
a21
ðqÞ
)
;
v2p
vqv _q
¼ edt
(
 2c1q
a21
)
;
v2p
v _q2
¼ edt
(
 2c1
a21
)
and
v2p
vq2
¼ edt
(
 2c1q
2
a21
)
:
Substituting these in Eq. (6), we have
d2Jð2Þ
d22

2¼0
¼ 2c1
a21
ZT
0
edtf _xþ xqg2dt<0:
This sufﬁcient condition ensures that J is a concave function in
[0,T]. The proof is completed.
Here,
d
dt

vp
v _q

¼ dedt
(
2c1
a21
ð _qÞ þ
 
pþ 2a0c1
a21
!
þ 2c1q
a21
ðqÞ
)
 edt
(
2c1
a21
ð€qÞ þ 2c1q
a21
ð _qÞ
)
Substituting the above derivatives in Eq.(5), we have, after
simpliﬁcation:
€q d _q qðqþ dÞq ¼ t (7)
where
t ¼ a
2
1
2c1
(
d
 
pþ 2a0c1
a21
!
þ 2c1qa0
a21
 pqþ c0qþ ch
)
:
Using the boundary conditions q(0) ¼ (R þ a0) and q(T) ¼ a0, we
have the solution of Eq. (7), i.e., the optimal path of q(t), as follows:
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qðqþ dÞ (8)where
AðRÞ ¼
2
64ðRþ a0ÞeðqþdÞT  a0 
tð1eðqþdÞTÞ
qðqþdÞ
eðqþdÞT  eqT
3
75 and BðRÞ
¼ 
2
64ðRþ a0ÞeqT  a0 
tð1eqTÞ
qðqþdÞ
eðqþdÞT  eqT
3
75
The optimal path of E(t) is
EðtÞ ¼ 1
a21

a0 
tq
qðqþ dÞ þ BðR; TÞð2qþ dÞe
ðqþdÞt
	2
(9)
Substituting the optimal paths q(t) and E(t) in Eq. (3), we have
J ¼ J1ðRÞ þ J2ðRÞ þ J3ðRÞ þ J4ðRÞ þ J5ðRÞ þ J6ðRÞ (10)
where
J1ðRÞ ¼ 
c1
a21
ZT
0
edtð _qÞ2dt ¼ c1
a21
 
q2A2
2qþ d
!
1 eð2qþdÞT

 c1B
2ðqþ dÞ2
a21ð2qþ dÞ
n
eð2qþdÞT  1
o
þ 2c1
a21
qABðqþ dÞT ;
J2ðRÞ ¼ 
 
pþ 2a0c1
a21
!ZT
0
edt _qdt
¼
 
pþ 2a0c1
a21
!
qA
qþ d

1 eðqþdÞT


 
pþ 2a0c1
a21
!


Bðqþ dÞ
q

eqT  1

;
J3ðRÞ ¼ 
2c1q
a21
ZT
0
edtq _qdt ¼ 2c1q
a21

qA2
2qþ d

1 eð2qþdÞT

 2c1q
a21
ABdT  2c1qAt
a21ðqþ dÞ2
n
1 eðqþdÞT
o
 2c1qB
2ðqþ dÞ
a21ð2qþ dÞ

eð2qþdÞT  1

þ 2c1Bt
a21q

eqT  1

;
J4ðRÞ ¼ 
c1q
2
a21
ZT
0
edtq2 dt ¼  c1q
2A2
a21ð2qþ dÞ

1 eð2qþdÞT

 c1q
2B2
a21ð2qþ dÞ

eð2qþdÞT  1

 c1t
2
a21dðqþ dÞ2

1 edT

 2c1q
2ABT
a21
þ 2c1tA
a21ðqþ dÞ

1 eðqþdÞT

þ 2c1tB
a21ðqþ dÞ

eqT  1

;J5ðRÞ ¼ 
2c1a0q
2  pqþ c0qþ ch
Z
edtq dt 
a1
! T
0
¼
 
2c1a0q
a21
 pqþ c0qþ ch
!



A
qþ d

1 eðqþdÞT

 B
q

eqT  1

þ t
qdðqþ dÞ

1 edT

and
J6ðRÞ ¼ 
 
c0Rþ
c1a20
a21
!ZT
0
edt dt
¼ 
 
c0Rþ
c1a20
a21
! 
1 edT
d
!
:
Substituting the above formulas of J
0s
i ði ¼ 1;2;…:6Þ in Eq. (10)
and simplifying, we have
J ¼ c1
a21
ð2qþ dÞ

eð2qþdÞT  1

B2 þ A
( 
pþ 2a0c1
a21
!
q
qþ d



1 eðqþdÞT

þ 2c1dt
a21ðqþ dÞ2

1 eðqþdÞT


 
2c1a0q
a21
 pqþ c0qþ ch
! 
1 eðqþdÞT
qþ d
!)
þ B
(

 
pþ 2a0c1
a21
!
qþ d
q

eqT  1

þ 2c1t
a21qðqþ dÞ
 ð2qþ dÞ

eqT  1


 
2c1a0q
a21
 pqþ c0qþ ch
!
eqT  1
)
þ
(
 c1t
21 edT
a21dðqþ dÞ2
þ
 
2c1a0
a21
 pþ c0 þ
ch
q
!


t
dðqþ dÞ

1 edT


 
c0Rþ
c1a20
a21
! 
1 edT
d
!)
(11)
Proposition 2: J(R) is also concave and a unimodal function of R.
Proof:
Now,
dJ
dR
¼2c1
a21
ð2qþ dÞ

eð2qþdÞT  1

B
 
eqT
eðqþdÞT  eqT
!
þ
 
eðqþdÞT
eðqþdÞT  eqT
!" 
pþ 2a0c1
a21
!
q
qþ d



1 eðqþdÞT

þ 2c1dt
a21ðqþ dÞ2

1 eðqþdÞT


 
2c1a0q
a21
 pqþ c0qþ ch
! 
1 eðqþdÞT
qþ d
!#

 
eqT
eðqþdÞT  eqT
!"

 
pþ 2a0c1
a21
!
qþ d
q

eqT  1

þ 2c1t
a21qðqþ dÞ
ð2qþ dÞ

eqT  1


 
2c1a0q
a21
 pqþ c0qþ ch
!
eqT  1
#

c0
d

1 eqT

(12)
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d2J
dR2
¼ 2c1
a21
ð2qþ dÞ

eð2qþdÞT  1
 eqT
eðqþdÞT  eqT
!2
<0: (13)
For optimum value of J, dJdR ¼ 0. This gives the optimum value of
R, which isa2c1
a21
ð2qþ dÞ

eð2qþdÞT  1
 eqT
eðqþdÞT  eqT
!2
Rþ 2c1
a21
ð2qþ dÞ

eð2qþdÞT  1
 teqT1 eqT
qðqþ dÞ

eðqþdÞT  eqT
2
þ
 
eðqþdÞT
eð2qþdÞT  eqT
!" 
pþ 2a0c1
a21
!
q
qþ d

1 eððqþdÞTÞ

þ 2c1dt
a21ðqþ dÞ2

1 eðqþdÞT


 
2c1a0q
a21
 pqþ c0qþ ch
! 
1 eðqþdÞT
qþ d
!

 
eqT
eðqþdÞT  eqT
!#

"

 
pþ 2a0c1
221
!
qþ d
q

eqT  1

þ 2c1t
a21qðqþ dÞ
ð2qþ dÞ

eqT  1


 
2c1a0q
a21
 pqþ c0qþ ch
!
eqT  1
#

c0
d

1 eqT

¼ 0!yieldsR ¼
"
2c1
a21
ð2qþ dÞ

eð2qþdÞT  1
 teqT1 eqT
qðqþ tÞ

eðqþdÞT  eqT
2 þ
 
eðqþdTÞ
eðqþdÞT  eqT
!

" 
pþ 2a0c1
a21
!
q
qþ d

1 eðqþdÞT

þ 2c1dt
a21ðqþ dÞ2

1 eðqþdÞT


 
2c1a0q
a21
 pqþ c0qþ ch
! 
1 eðqþdÞT
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Fig. 1. Optimal level of inventory versus time.5. Numerical example
We consider the values of key parameters in appropriate units
as follows: a0 ¼ 50 units, a1 ¼ 10 units, T ¼ 3 months, q ¼ 0.05,
d ¼ 0.06, ch ¼ $ 1.5, c0 ¼ $ 10, c1 ¼ $ 3, and p ¼ $ 40. Then, the
required optimal solution is R* ¼ 379.82 units, E*0 ¼ 126:51 units
and J* ¼ $851.005. The optimal path of inventory (Fig. 1) declines
sharply when adjusting demand D(E). Similarly, the optimal path of
sales team initiatives E(t) (Fig. 2) decreases with time because the
stock of inventory decreases with time. Another reason is that more
initiatives are needed to boost the sales of the higher stock of the
products as well as for the introduction of new products in the
market. The demand and deterioration of the product over time t
are shown in Fig. 3. The mathematical analysis and Fig. 4 indicate
that J(R) is a strictly concave function of R. Moreover, the optimal
solution of themodel is R*¼ 209.89 units, R*¼ 209.89, E*0 ¼ 126:51units and J* ¼ $ 768.73 when a0 ¼ 0, i.e., the demand of the cus-
tomers is fully dependent on sales team initiatives.6. Sensitivity analysis of the key parameters and managerial
insights
We have conducted sensitivity analysis for the key parameters
of the model. The optimal solutions for (50%, 25%, þ25%, þ50%)
changes of one parameter were obtained (see Table 1), keeping the
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Fig. 4. Proﬁt (J) versus replenishment size (R).
Table 1
Sensitivity analysis of the key parameters.
Parameter
(Change in %)
R* E*0 J
*
a0 50% 294.85 126.51 809.87
25% 337.33 126.51 830.44
þ25% 422.30 126.51 871.57
þ50% 464.78 126.51 892.14
a1 50% 222.40 31.63 274.45
25% 289.99 71.16 514.68
þ25% 497.88 197.67 1283.42
þ50% 642.18 284.64 1811.92
Fig. 2. Optimal initiatives of sales team versus time.
S.S. Sana et al. / Paciﬁc Science Review B: Humanities and Social Sciences 1 (2015) 15e2120other parameters ﬁxed. From the sensitivity analysis, the following
natural phenomena are observed:
 The optimal values ðR*; E*0; J*Þ are moderately sensitive with
changes of the ﬁxed demand rate (a0). As the ﬁxed demand rate
(i.e., ﬁxed customer demand rate) increases, the replenishment
lot size (R*) increases, which results in a higher proﬁt. On the
other hand, the initial level of the initiatives of the sales team
ðE*0Þ is unchanged because the scale parameter (a1) is ﬁxed. This
is quite rational in real life problems.
 The optimal values ðR*; E*0; J*Þ are highly sensitive with changes
in the scale parameter (a1) of the demand function. Higher
values of a1 result in more effort from the sales team to increase
the demand for the items. As a result, the replenishment lot
sizes and proﬁts are higher due to more demand.
 When the deterioration rate (q) increases, the replenishment lot
size decreases to avoid more loss due to higher deterioration.
The initial effort level ðE*0Þ decreases with decreases in the lot
size, and the proﬁt (J*) occasionally decreases due to higher
deterioration.Time: t
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Fig. 3. Demand rate and perishable items versus time. The optimal values ðR*; E*0; J*Þ are fairly sensitive to changes in
the inventory holding cost(ch). As the scale parameter a1 of the
initiatives of the sales team is ﬁxed, the initial effort level of the
sales team is insensitive to changes in ch. However, the initial
optimum replenishment lot size decreaseswith increases in ch to
avoid greater costs for holding more inventory. The proﬁt de-
creases automatically with increases in inventory holding cost.
 The optimal replenishment lot size, initial effort level and proﬁt
decreasewith increases in values of purchasing cost (c0) per unit
item. Here, the optimal solutions ðR*; E*0; J*Þ are highly sensitiveq 50% 459.61 258.11 1621.45
25% 421.45 186.40 1233.03
þ25% 334.45 78.35 479.62
þ50% 285.08 41.81 123.45
ch 50% 449.56 126.51 1241.74
25% 414.69 126.51 1034.50
þ25% 344.94 126.51 691.26
þ50% 310.07 126.51 555.25
c0 50% 1284.02 1164.63 12,550.40
25% 831.92 514.70 5107.93
þ25% Not feasible Not feasible Not feasible
þ50% Not feasible Not feasible Not feasible
c1 50% 589.71 506.03 1619.74
25% 449.78 224.90 1107.25
þ25% 337.84 80.96 697.26
þ50% 309.85 56.22 594.76
p 50% Not feasible Not feasible Not feasible
25% Not feasible Not feasible Not feasible
þ25% 919.26 650.20 6362.59
þ50% 1458.71 1580.71 16415.90
d 50% 393.14 81.54 697.84
25% 386.81 103.10 770.94
þ25% 372.15 151.57 937.62
þ50% 363.80 178.12 1030.41
T 50% 737.43 1732.76 16,637.40
25% 746.81 747.87 6093.17
þ25% Not feasible Not feasible Not feasible
þ50% Not feasible Not feasible Not feasible
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higher. This occurs due to loss of the objective function.
 The optimal values ðR*; E*0; J*Þ are highly sensitive with changes
of the cost parameter (c1) of the effort of the sales teams. A
higher value of c1 reduces the effort level of the objective
function. Consequently, the demand rate decreases with in-
creases in the effort level, and the replenishment lot size de-
creases to avoid greater inventory cost.
 The optimal values ðR*; E*0; J*Þ are highly sensitive to the selling
price (p) per unit item. The initial initiatives ðE*0Þ and replen-
ishment lot size increase due to higher revenue earned from
selling the items. Consequently, demand and proﬁt increase due
to a higher selling price of the items. The lower sales prices
(50% & 25% changes in p) have no feasible solutions in this
model.
 When the parameter d increases, the value of the proﬁt de-
creases to avoid greater inventory cost and the initial effort level
increases to clear stock rapidly.
 When the cycle time (T) increases, the replenishment lot size
decreases to reduce the cost for holding inventory. As the
replenishment lot size is smaller, the initial initiative level de-
creases to adjust to the demand of the customers. Here, the
proﬁt reduces for a longer cycle time (T) due to inﬂation and
time value of money tied up for the whole system. The model
also has no feasible solutions for higher values of T, þ25%
& þ50% changes in T.
In the above analysis, based on the values of cost and proﬁt
parameters, this model suggests how a manager of a ﬁrm could
order the lot size and adjust the investment in the sales team to
achieve the maximum proﬁt.
7. Conclusion
In practice, pharmaceutical products may undergo deterioration
over time. The deterioration includes decay, spoilage, evaporation,
obsolescence and pilferage, which increase with on-hand in-
ventory. Therefore, a larger stock of the products for a long period of
time causes higher loss due to deterioration and inventory cost.
Therefore, the optimal stock/replenishment order size should be
sold within a short period of time. Consequently, more sales team
initiatives are required to clear the stock within the stipulated
period. The sales team initiatives are also important for launching
new products in the market. Moreover, our model considers the
inﬂation and time value of money for the cost and proﬁt parame-
ters, which so far has only been considered in a few articles. Our
model helps amanager of a farm determine the optimal lot size and
volume of sales team initiatives so that the total proﬁt can be
maximized.
The proposed model can be extended further for the time
dependent perishable rate, which is relaxed in this model for the
sake of simplicity. The continuous nature of sales team initiatives
are considered in this model, which is also a limitation of this
model. Another limitation of the model is a deterministic replen-
ishment rate that is available instantaneously and inﬁnitely in the
market. This situation may arise when supply disruption does not
occur, which is not possible all the time. Consequently, this model
can be extended in the future by considering the discrete proba-
bilistic replenishment rate as well as the demand rate.References
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